Stephen Sherwin, Director at Biogen, holds 13.69K shares in Biogen (Ticker: BIIB), holds 13.54K shares in Neurocrine (Ticker: NBIX), holds 0.00 shares in Neon Therapeutics (Ticker: NTGN).
Stephen Sherwin latest transaction was an Uninformative Buy of ―.
What was Stephen Sherwin's most profitable transaction?
Stephen Sherwin’s most profitable transaction was an Informative Sell of BIIB stock on March 10, 2025. The return on the trade was 17.00%.
What is Stephen Sherwin's role in Biogen?
Stephen Sherwin's role in Biogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.